Toward a functional taxonomy of cancer

被引:8
作者
Golub, TR [1 ]
机构
[1] MIT, Broad Inst, Cambridge, MA 02141 USA
[2] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Howard Hughes Med Inst, Coconut Grove, FL 33133 USA
关键词
D O I
10.1016/j.ccr.2004.08.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interrogating the genomes of tumor cells with genomic and proteomic methods is becoming a mainstay of modern cancer classification efforts. This notion is brought to a new level by a paper in the July 23 issue of Cell, in which the dynamic responses of leukemia cells to perturbation are cataloged by flow cytometry, and the leukemias classified in terms of their functional responses. This study paves the way for more systematic attempts to bring functional genomics to the study of human cancer.
引用
收藏
页码:107 / 108
页数:2
相关论文
共 5 条
[1]   Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia [J].
Bullinger, L ;
Döhner, K ;
Bair, E ;
Fröhling, S ;
Schlenk, RF ;
Tibshirani, R ;
Döhner, H ;
Pollack, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1605-1616
[2]   Single cell profiling of potentiated phospho-protein networks in cancer cells [J].
Irish, JM ;
Hovland, R ;
Krutzik, PO ;
Perez, OD ;
Bruserud, O ;
Gjertsen, BT ;
Nolan, GP .
CELL, 2004, 118 (02) :217-228
[3]   The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma [J].
Rosenwald, A ;
Wright, G ;
Chan, WC ;
Connors, JM ;
Campo, E ;
Fisher, RI ;
Gascoyne, RD ;
Muller-Hermelink, HK ;
Smeland, EB ;
Staudt, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (25) :1937-1947
[4]   Prognostically useful gene-expression profiles in acute myeloid leukemia [J].
Valk, PJM ;
Verhaak, RGW ;
Beijen, MA ;
Erpelinck, CAJ ;
van Doorn-Khosrovani, SBV ;
Boer, JM ;
Beverloo, HB ;
Moorhouse, MJ ;
van der Spek, PJ ;
Löwenberg, B ;
Delwel, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1617-1628
[5]   A gene-expression signature as a predictor of survival in breast cancer. [J].
van de Vijver, MJ ;
He, YD ;
van 't Veer, LJ ;
Dai, H ;
Hart, AAM ;
Voskuil, DW ;
Schreiber, GJ ;
Peterse, JL ;
Roberts, C ;
Marton, MJ ;
Parrish, M ;
Atsma, D ;
Witteveen, A ;
Glas, A ;
Delahaye, L ;
van der Velde, T ;
Bartelink, H ;
Rodenhuis, S ;
Rutgers, ET ;
Friend, SH ;
Bernards, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :1999-2009